Combination chemotherapy with anticancer agents and OK-432.
D000368:Aged; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage* / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage / Q000627:therapeutic use; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008113:Liver Neoplasms / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D051379:Mice; D008875:Middle Aged; D008937:Mitomycins / Q000008:administration & dosage / Q000627:therapeutic use; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D012510:Sarcoma 180 / Q000188:drug therapy; D013291:Streptococcus / Q000032:analysis; D014184:Transplantation, Homologous
D000903:Antibiotics, Antineoplastic; D008937:Mitomycins; D009588:Nitrogen Mustard Compounds; D001761:Bleomycin; D003520:Cyclophosphamide